Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. 1995

V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
Centre de Biochimie, CNRS-UMR134, Parc Valrose, Nice, France.

We have compared the desensitization of two receptors, the thrombin receptor which displays dual coupling to both pertussis toxin-sensitive (Gi) and -insensitive (Gq) proteins and the serotonin type 2 (5-HT2) receptor which selectively couples to Gq. In the case of the thrombin receptor, cleavage induces activation and irreversible receptor modification followed by rapid (T1/2 = 3 min) and extensive desensitization of the receptor's ability to modulate phospholipase C (Gq). 5-HT-induced desensitization of its receptor is markedly slower (T1/2 = 10 min) and by 60 min only 50% of the phospholipase C response is lost. This effect occurs with a parallel disappearance of 5-HT receptors from the cell surface. Whole cell phosphorylation studies showed that the thrombin receptor is rapidly phosphorylated upon activation. In contrast, the 5-HT2 receptor displays a low basal level of phosphorylation which is not increased upon agonist treatment. The cytoplasmic tail of the 5-HT2 receptor which contains several protein kinase consensus sequences was found not to be involved in receptor activation or desensitization. However, a chimeric receptor having the core of the 5-HT2 receptor and the cytoplasmic tail of the thrombin receptor was able to undergo 5-HT-induced desensitization and phosphorylation. These results indicate that (i) both 5-HT2 and thrombin receptors have unique shut-off mechanisms, and (ii) that sequences in the carboxyl terminus of the thrombin receptor are sufficient to trigger rapid uncoupling of the receptor from its G protein(s) and downstream effector(s).

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
July 1993, European journal of pharmacology,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
December 1993, Brain research,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
January 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
September 1993, Journal of studies on alcohol. Supplement,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
October 1991, The Journal of pharmacology and experimental therapeutics,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
January 1988, Journal of cardiovascular pharmacology,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
June 1991, European journal of pharmacology,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
January 1991, Journal of neurology,
V Vouret-Craviari, and P Auberger, and J Pouysségur, and E Van Obberghen-Schilling
March 1992, European journal of pharmacology,
Copied contents to your clipboard!